Related Experiment Video
Updated: May 29, 2026
Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Small bowel capsule endoscopy impacts diagnosis and management of pediatric inflammatory bowel disease: a prospective
Ian M Gralnek1, Stanley A Cohen, Hagit Ephrath
1Department of Gastroenterology, Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, GI Outcomes Unit, Rambam Health Care Campus, Haifa, Israel. i_gralnek@rambam.health.gov.il
Insights
Capsule endoscopy (CE) aids in diagnosing pediatric inflammatory bowel disease (IBD), often confirming Crohn's disease (CD) and changing management. CE reclassifies IBD types and reveals more extensive small bowel disease in diagnosed patients.
Area of Science:
- Pediatric Gastroenterology
- Diagnostic Imaging
Background:
- Accurate inflammatory bowel disease (IBD) classification is crucial for pediatric patient management and outcomes.
- Capsule endoscopy (CE) is an emerging tool for evaluating suspected or known IBD in children.
Purpose of the Study:
- To assess the utility of capsule endoscopy (CE) in classifying pediatric inflammatory bowel disease (IBD).
- To evaluate the impact of CE findings on physician decision-making and patient management in pediatric IBD.
Main Methods:
- Prospective cohort study involving pediatric patients with suspected or known IBD.
- Physicians completed pre- and post-CE questionnaires regarding diagnosis, management, and CE impact.
- Analysis of CE findings in relation to IBD classification and treatment adjustments.
Main Results:
- CE led to definitive Crohn's disease (CD) diagnosis in 80% of "suspected" IBD cases.
- 50% of ulcerative/indeterminate colitis (UC/IC) patients were reclassified to CD post-CE.
- CE identified more proximal small bowel disease in 50% of known CD patients.
- Physicians reported CE aided diagnosis (83.3%) and impacted management decisions (72.2%).
Conclusions:
- Capsule endoscopy is valuable for diagnosing pediatric IBD, particularly Crohn's disease.
- CE facilitates IBD type reclassification and can reveal a greater disease burden.
- Integrating CE into pediatric IBD evaluation can optimize medical management and improve patient outcomes.
Purpose:
Accurately classifying inflammatory bowel disease (IBD) type in pediatric patients may impact medical decision-making, direct therapy, and improve outcomes.
Methods:
This was a prospective cohort study evaluating classification of IBD and patient management with use of capsule endoscopy in pediatric patients with suspected or known IBD. Treating physicians completed a questionnaire before and after capsule endoscopy (CE) assessing clinical suspicion of Crohn's disease (CD) diagnosis, patient management decisions, and perceived impact of CE findings.
Results:
Eighteen subjects [11F/7M, mean age 13.8 (± 2.5) years], 4 previously diagnosed with CD, 4 with ulcerative or indeterminate colitis (UC/IC), and 10 "suspected" to have IBD were included. Following CE, 2 of 4 (50%) UC/IC patients were reclassified as having small bowel CD. In the 4 subjects with known CD, 2 (50%) had CE evidence of more proximal small bowel mucosal disease than previously recognized. In the 10 subjects with "suspected" IBD, 8 (80%) had SB ulcerations leading to a definitive diagnosis of CD. Treating physicians reported CE helped diagnosing CD in 15 of 18 (83.3%) subjects and impacted medical decision-making in 13 of 18 (72.2%), leading to a change in medical management in 14 of 18 (77.8%).
Conclusions:
In "suspected" pediatric IBD, CE often leads to a definitive diagnosis of CD. CE can lead to reclassification of IBD from UC/IC to CD and previously diagnosed CD patients may have a more significant burden of small bowel disease. These data may help integrate CE in evaluating IBD patients, lead to more targeted medical management changes and improve outcomes.
Related Concept Videos
01:28Endoscopic Procedures III: Video Capsule Endoscopy
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
01:26Endoscopic Procedures V: ERCP
Patient...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...